Search Results 201-210 of 16050 for pharmacogenetics
Education and counseling about cancer risk, cancer risk reduction, effective screening and prevention options are key aspects of the program. Clinical genetic ...
About this study. The purpose of this study is to identify patients with rare genetic disorders that may potentially benefit from an ASO therapeutic based ...
The Epigenomics and Spatial Biology Core in the Center for Cell Signaling in Gastroenterology at Mayo Clinic provides novel epigenomics and spatial biology ...
This medicine is to be given only by or under the supervision of your doctor or other health care professional. This product is available in the following ...
Collaborators. Dr. Schaid and his statistical team work with world-class experts in disease and many areas of human genetics, ranging from molecular biology ...
Section=1. Section 1=Test section onexxxxxxxxxxxxxxxxxxxxxxxx. Content can go here.
The Genome Analysis Core at Mayo Clinic offers DNA and RNA next-generation sequencing (NGS), gene expression and genotyping services for researchers.
A PSP genome-wide association study (GWAS) identified six novel risk loci, in addition to the established H1 haplotype on chromosome 17 at the tau gene (MAPT) ...
The purpose of this study is to analyze genome-wide methylation patterns in DNA from patients with suspected hereditary disorders but for whom all previous ...
Albinism. · Birthmarks. · Carney complex. · Cowden syndrome. · Cutaneous mosaicism. · Cutis laxa. · Dyskeratosis congenita. · Ectodermal dysplasia.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.